Graybug
IPOGraybug has $1.7M in recorded funding across 1 round.
- Business Model
- B2B
- Total Funding
- $1.7M
- Last Round
- $1.7M Series AMar 2015
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Clinical-stage ophthalmology company developing sustained-release therapies.
Summary
Graybug is a Biotech company. It has raised $1.7M in total across 1 round, most recently a $1.7M Series A round in Mar 2015. Investors include Hatteras Venture Partners and Maryland Venture Fund.
Funding History
Mar 2015
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/graybug"><img src="https://indexed.vc/api/badge/company/graybug" alt="Graybug on Indexed.vc" width="260" height="76" /></a>